Ginkgo Bioworks Holdings Inc (NYSE: DNA) flaunted slowness of -15.00% at $7.31, before settling in for the price of $8.60 at the close. Taking a more long-term approach, DNA posted a 52-week range of $5.26-$75.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 104.75%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 55.05%. This publicly-traded company’s shares outstanding now amounts to $38.13 million, simultaneously with a float of $35.43 million. The organization now has a market capitalization sitting at $421.58 million. At the time of writing, stock’s 50-day Moving Average stood at $7.77, while the 200-day Moving Average is $24.07.
Ginkgo Bioworks Holdings Inc (DNA) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Ginkgo Bioworks Holdings Inc industry. Ginkgo Bioworks Holdings Inc’s current insider ownership accounts for 32.60%, in contrast to 41.30% institutional ownership.
Ginkgo Bioworks Holdings Inc (DNA) Earnings and Revenue Records
Ginkgo Bioworks Holdings Inc’s EPS increase for this current 12-month fiscal period is 55.05% and is forecasted to reach -6.57 in the upcoming year.
Ginkgo Bioworks Holdings Inc (NYSE: DNA) Trading Performance Indicators
Let’s observe the current performance indicators for Ginkgo Bioworks Holdings Inc (DNA). It’s Quick Ratio in the last reported quarter now stands at 5.79. The Stock has managed to achieve an average true range (ATR) of 0.75. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.93.
In the same vein, DNA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -12.90, a figure that is expected to reach -1.73 in the next quarter, and analysts are predicting that it will be -6.57 at the market close of one year from today.
Technical Analysis of Ginkgo Bioworks Holdings Inc (DNA)
Now, what If we examine the latest scores posted by [Ginkgo Bioworks Holdings Inc, DNA]. During the last 5-days, its volume was better the volume of 1.14 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 37.00% While, its Average True Range was 0.81.
Raw Stochastic average of Ginkgo Bioworks Holdings Inc (DNA) in the period of the previous 100 days is set at 18.42%, which indicates a major rise in contrast to 5.15% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 80.24% that was lower than 112.15% volatility it exhibited in the past 100-days period.
